Population
Children with hypertension
Design
Review
Authors
Loading...
Clinicians face limited evidence-based options in pediatric hypertension; leaves open the need for dedicated age-specific trials.
Highlights the historical lack of pediatric-specific data and formulations for antihypertensive drugs and emphasizes the need for rigorous trials addressing unique pediatric aspects.
Joseph T. Flynn (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: